- STTR Grant will Support Development of Advanced Sample Sorting Capabilities and Enhancements in Chip Design for Applications in Cancer
Diagnostics and Research -
PHILADELPHIA, Sept. 24 /PRNewswire/ -- BioNanomatrix, Inc., today announced that the company and Princeton University are recipients of a new Small Technology Transfer Research (STTR) grant from the National Cancer Institute (NCI) of the U.S. National Institutes of Health (NIH). The two-year, $200,000 grant is focused on development of integrated fluidics systems for the front end sample sorting component of the BioNanomatrix whole genome analytic platform. The goal of the project is to develop integrated systems that can separate out and sort whole chromosomes from a single cell or multiple cells. This type of cell fractionation is a key early step in the analytic process.
"This new NCI grant will enable us to continue to collaborate with Princeton researchers to develop enhanced front-end capabilities for our analytic platform," said Han Cao, Ph.D., chief scientific officer of BioNanomatrix.
BioNanomatrix is developing pioneering integrated systems that enable nanoscale single molecule identification and analysis of the entire genome, delivering single molecule sensitivity in a highly parallel format. The company's patented analytic platform based on this technology provides rapid, comprehensive and cost effective ultra-high resolution analyses of DNA.
"The core BioNanomatrix nanofluidics technology was originally
developed at Princeton and we look forward to continuing to collaborate to
further develop its utility for applications in both biomedical research
and clinical medicine," said Professor James Sturm, co-investigator of the
project and William and Edna Macaleer Professor of Engineering and Applied
Science, Professor of Electrical Engineering and Director of the Princeton
Institute for the Science and Technology of Materials (PRISM)
Copyright©2007 PR Newswire.
All rights reserved